missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Phospho-DARPP-32 (Thr34) Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Marke: Invitrogen PA539693
Additional Details : Gewicht : 0.00900kg
Beschreibung
Dopaminergic signaling pathways, which are essential for multiple brain functions, are abnormal in several neurological disorders, such as schizophrenia, Parkinson′s disease and drug abuse. DARPP-32 (for dopamine and adenosine 3′,5′-monophosphate-regulated phosphoprotein of 32 kDa) is abundant in neurons that receive dopaminergic input. Activation of PKA and the consequent phosphorylation of DARPP-32 on threonine occurs in response to dopamine acting upon D1-like receptors. Dopamine interaction with D2-like receptors results in the inhibition of PKA activation, the activation of protein phosphatase 2B and the consequent dephosphorylation of DARPP-32. Neurotransmitters other than dopamine may also be able to stimulate the phosphorylation or dephosphorylation of DARPP-32. Phosphorylated DARPP-32 is a potent inhibitor of PP-1.Spezifikation
Phospho-DARPP-32 (Thr34) | |
Polyclonal | |
Unconjugated | |
PPP1R1B | |
Protein phosphatase 1 regulatory subunit 1B, DARPP-32, Dopamine- and cAMP-regulated neuronal phosphoprotein, PPP1R1B, DARPP32 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
19049, 360616, 84152 | |
-20°C | |
Liquid |
Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
Dulbecco′s PBS with 150mM NaCl, 50% glycerol and 0.02% sodium azide; pH 7.4 | |
Q9UD71, Q60829, Q6J4I0 | |
PPP1R1B | |
A synthetic phosphopeptide derived from human DARPP-32 around the phosphorylation site of Thr34 (R-P-TP-P-A) | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |